DEA Regulatory Actions

Staff Writers
June 30, 2010 at 20:00:00 ET
  DEA Officials Confirm Levmetamfetamine Exclusion In a final rule published March 23, 2010, the Drug Enforcement Administration confirmed that certain over-the-counter nasal decongestant inhaler/vapor inhaler products containing 50 mg levmetamfetamine would continue to be listed as excluded nonnarcotic products (75 FR 13,658). The products had tentatively been grante... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.